Addenda Capital’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
AT
CIM
MPWT
NAM
CNB
LTAS
COPPSERS
Addenda Capital's RMD Position: Q2 2026 in Review
Addenda Capital reduced its ResMed (RMD) stake by 0.83% in Q2 2026, selling an estimated $134K and leaving 77,707 shares worth $15.1M. The position accounts for 0.41% of the portfolio, ranked #56.
Addenda Capital first reported a position in RMD in Q1 2018 and has held it in 17 quarters since. The position peaked at $21.2M in Q3 2025. 103 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Addenda Capital held 77,707 shares of ResMed worth $15.1M as of Q2 2026.
- Addenda Capital sold 648 ResMed shares in Q2 2026, an estimated $134K.
- ResMed made up 0.41% of Addenda Capital's portfolio in Q2 2026, its #56 holding.
- Addenda Capital first reported a position in ResMed in Q1 2018 and has held it in 17 quarters since.
- Addenda Capital's ResMed position peaked at $21.2M in Q3 2025.
- 103 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Addenda Capital's 13F filing for Q2 2026, filed 14 Jul 2026.